Congenital Hyperinsulinism in Infancy and Childhood: Pathophysiology, Diagnosis, and Management
So Hee Lee
(Department of Pediatrics, Daegu Catholic University School of Medicine, Daegu Catholic University Medical center, Daegu, Korea)
Eun Ah Kim
(Department of Pediatrics, Daegu Catholic University School of Medicine, Daegu Catholic University Medical center, Daegu, Korea)
Jin Kyung Kim
(Department of Pediatrics, Daegu Catholic University School of Medicine, Daegu Catholic University Medical center, Daegu, Korea)
Journal of Interdisciplinary Genomics / Journal of Interdisciplinary Genomics, (E)2671-6771
2025, v.7 no.2, pp.32-37
https://doi.org/10.22742/JIG.2025.7.2.32
Lee,
S. H., Kim,
E. A., &
Kim,
J.
K.
(2025). Congenital Hyperinsulinism in Infancy and Childhood: Pathophysiology, Diagnosis, and Management, 7(2), 32-37, https://doi.org/10.22742/JIG.2025.7.2.32
Abstract
Congenital hyperinsulinism (CHI) is the leading cause of severe and persistent hypoglycemia in infants and children. Hyperinsulinemic hypoglycemia (HH) represents a clinically and genetically heterogeneous disorder, manifesting as transient forms related to perinatal stress or persistent forms caused by molecular defects in the genes regulating insulin secretion from pancreatic β-cell. Pathogenic variants in the KATP channel genes (ABCC8, KCNJ11) are the most frequent causes, although variants in other channels/transporter, metabolic enzymes, and transcription factors have also been reported. Syndromic forms associated multisystemic disorders also recognized. Prompt recognition of hypoglycemia, determination of its underlying etiology, and appropriate management are crucial to prevent irreversible neurodevelopmental impairment.
- keywords
-
Hypoglycemia,
Hyperinsulinism,
Insulin,
Diazoxide
- Received
- 2025-10-13
- Revised
- 2025-10-29
- Accepted
- 2025-10-29
- Published
- 2025-10-31